Gujarat Themis Biosyn Limited (NSE:GUJTHEM)
349.55
+15.80 (4.73%)
At close: Jun 16, 2025, 3:30 PM IST
Gujarat Themis Biosyn Company Description
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India.
The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis; Rifamycin-O; and Lovastatin.
The company was incorporated in 1981 and is based in Mumbai, India.
Gujarat Themis Biosyn Limited
Country | India |
Founded | 1981 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 159 |
CEO | Tapas Guhathakurata |
Contact Details
Address: Themis House Mumbai, Gujarat 400104 India | |
Phone | 91 22 6760 7080 |
Website | gtbl.in |
Stock Details
Ticker Symbol | GUJTHEM |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Tapas Bhudebendranath Guhathakurata | Chief Executive Officer |
Bhavik Shah | Chief Financial Officer |
Do-Seon Kim | Chief Technical Officer |
Vineet G. Gawankar | Company Secretary and Compliance Officer |
Rajneesh Kedarnath Anand | Senior Executive |